Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
News
Pharmacies Excluded from Preferred Networks Face Much Higher Risk of Closure
Featured Experts: Dima M. Qato
In The News View All
Modern Healthcare
States are likely to pursue PBM legislation in the absence of federal action, Joyce says
Featured Experts: Geoffrey Joyce
Law360
Lawmakers shouldn’t overlook value of rare disease therapies, Chen argues
Featured Experts: Alice Chen
Medscape
Medicare coverage of obesity drugs could presure other insurers to follow suit, Ward says
Featured Experts: Alison Sexton Ward
Oprah Daily
Qato discusses disparities in GLP-1 coverage
Featured Experts: Dima M. Qato
Bloomberg Law
The first round of Medicare drug negotiations lacked true transparency, Lakdawalla explains
Featured Experts: Darius Lakdawalla
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
